Overview
Neural tube defects (NTDs) are a group of congenital malformations that occur when the neural tube — the embryonic structure that develops into the brain and spinal cord — fails to close completely during the first few weeks of pregnancy (typically between days 21 and 28 after conception). This group of conditions includes several well-known subtypes: anencephaly (absence of a major portion of the brain and skull), spina bifida (incomplete closure of the spinal column), and encephalocele (protrusion of brain tissue through an opening in the skull). The severity of NTDs ranges widely, from conditions incompatible with life (such as anencephaly) to milder forms like spina bifida occulta, which may be asymptomatic. The clinical features depend on the type and location of the defect. Spina bifida, the most common survivable form, can cause varying degrees of paralysis of the lower limbs, bladder and bowel dysfunction, hydrocephalus (accumulation of cerebrospinal fluid in the brain), orthopedic abnormalities, and learning difficulties. Anencephaly is uniformly fatal, with most affected infants being stillborn or dying shortly after birth. Encephalocele can cause intellectual disability, vision problems, and motor deficits depending on the amount of brain tissue involved. Neural tube defects have a multifactorial etiology involving both genetic susceptibility and environmental factors. Maternal folate (folic acid) deficiency is the best-established modifiable risk factor, and periconceptional folic acid supplementation has been shown to reduce the risk of NTDs by up to 70%. Other risk factors include maternal diabetes, obesity, certain anticonvulsant medications (particularly valproic acid), and genetic variants in folate metabolism pathways (such as MTHFR). Treatment depends on the specific defect: spina bifida may be treated with surgical closure of the defect either prenatally (fetal surgery) or shortly after birth, along with management of hydrocephalus through ventriculoperitoneal shunting. Lifelong multidisciplinary care involving neurosurgery, urology, orthopedics, and rehabilitation is often required for individuals with spina bifida. Prevention through folic acid fortification of food and supplementation remains the cornerstone of public health strategy.
Multifactorial
Caused by a mix of several genes and environmental factors
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
10 eventsShanghai Institute of Acupuncture, Moxibustion and Meridian — NA
Mount Sinai Hospital, Canada — NA
South Valley University — NA
Xuanwu Hospital, Beijing — NA
Western University, Canada
Beth Israel Deaconess Medical Center — NA
Michael A Belfort — NA
Baylor College of Medicine — PHASE1
USFetus — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Neural tube defect.
6 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Neural tube defect.
Community
No community posts yet. Be the first to share your experience with Neural tube defect.
Start the conversation →Latest news about Neural tube defect
Disease timeline:
New recruiting trial: Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida
A new clinical trial is recruiting patients for Neural tube defect
New recruiting trial: Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele
A new clinical trial is recruiting patients for Neural tube defect
New recruiting trial: In Utero Surgery for Fetal Myelomeningocele: Decision-making Mechanisms and Psychological Impact of Prenatal Therapy
A new clinical trial is recruiting patients for Neural tube defect
New recruiting trial: Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial
A new clinical trial is recruiting patients for Neural tube defect
New recruiting trial: In-Utero Endoscopic Correction of Spina Bifida
A new clinical trial is recruiting patients for Neural tube defect
New recruiting trial: Impact of Standing Programs in Children With Spina Bifida: A Single Subject Design
A new clinical trial is recruiting patients for Neural tube defect
New recruiting trial: Brain Health With Inner Engineering Meditation
A new clinical trial is recruiting patients for Neural tube defect
New recruiting trial: Evaluation of muLtimodal and Non-invasive SPINa Bifida Neurovessels During Prospective Follow-up
A new clinical trial is recruiting patients for Neural tube defect
New recruiting trial: Fetoscopic Neural Tube Defect Repair
A new clinical trial is recruiting patients for Neural tube defect
New recruiting trial: QUALAS Validation in Dutch
A new clinical trial is recruiting patients for Neural tube defect
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Neural tube defect
What is Neural tube defect?
Neural tube defects (NTDs) are a group of congenital malformations that occur when the neural tube — the embryonic structure that develops into the brain and spinal cord — fails to close completely during the first few weeks of pregnancy (typically between days 21 and 28 after conception). This group of conditions includes several well-known subtypes: anencephaly (absence of a major portion of the brain and skull), spina bifida (incomplete closure of the spinal column), and encephalocele (protrusion of brain tissue through an opening in the skull). The severity of NTDs ranges widely, from cond
How is Neural tube defect inherited?
Neural tube defect follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Neural tube defect typically begin?
Typical onset of Neural tube defect is neonatal. Age of onset can vary across affected individuals.
Are there clinical trials for Neural tube defect?
Yes — 6 recruiting clinical trials are currently listed for Neural tube defect on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Neural tube defect?
25 specialists and care centers treating Neural tube defect are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.